HCID 9795017, 화합물 → HCID 20306171, 화합물

반응식

[O:1]=[C:2]1[CH2:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[S:5](=[O:14])(=[O:13])[C:4]2[CH:15]=[C:16]([CH2:19][C:20](O)=[O:21])[CH:17]=[CH:18][C:3]1=2.C1C2C=CC3C=CC=CC=3SC=2C=C(C(O)=O)C=1>>[OH:21][CH2:20][CH2:19][C:16]1[CH:17]=[CH:18][C:3]2[C:2](=[O:1])[CH2:8][C:7]3[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=3[S:5](=[O:14])(=[O:13])[C:4]=2[CH:15]=1

참가 물질

반응물 2

HCID 9795017HCID 9795017, 화합물

HCID 54255076HCID 54255076, 화합물

생성물 1

HCID 20306171HCID 20306171, 화합물

실험 절차

Repeat the process of Example 6, substituting an equivalent quantity of 10,11-dihydro-11-oxodibenzo[b,f]thiepin-3-acetic acid 5,5-dioxide for the dibenzo[b,f]thiepin-3-carboxylic acid, to obtain the title product.

출처 및 근거

ORD 기록: ord-4d73be244fa94b558814edf898344ae3
출처 데이터셋: uspto-grants-1980_12
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US04237160

반응 노트

불러오는 중…